1. Home
  2. SPB vs NTLA Comparison

SPB vs NTLA Comparison

Compare SPB & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spectrum Brands Holdings Inc.

SPB

Spectrum Brands Holdings Inc.

HOLD

Current Price

$79.92

Market Cap

1.8B

Sector

Miscellaneous

ML Signal

HOLD

Logo Intellia Therapeutics Inc.

NTLA

Intellia Therapeutics Inc.

HOLD

Current Price

$11.17

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPB
NTLA
Founded
1906
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.6B
IPO Year
1994
2016

Fundamental Metrics

Financial Performance
Metric
SPB
NTLA
Price
$79.92
$11.17
Analyst Decision
Buy
Buy
Analyst Count
9
20
Target Price
★ $98.75
$23.11
AVG Volume (30 Days)
291.2K
★ 5.0M
Earning Date
11-12-2026
11-05-2026
Dividend Yield
★ 2.32%
N/A
EPS Growth
N/A
★ 27.43
EPS
★ 1.01
N/A
Revenue
★ $3,802,100,000.00
$67,671,000.00
Revenue This Year
$1.92
N/A
Revenue Next Year
$1.26
$143.36
P/E Ratio
$80.07
★ N/A
Revenue Growth
★ 20.86
16.92
52 Week Low
$51.41
$7.95
52 Week High
$99.06
$18.48

Technical Indicators

Market Signals
Indicator
SPB
NTLA
Relative Strength Index (RSI) 48.60 40.32
Support Level $77.74 $10.15
Resistance Level $80.83 $13.50
Average True Range (ATR) 1.77 0.76
MACD 0.61 -0.09
Stochastic Oscillator 81.51 20.26

Price Performance

Historical Comparison
SPB
NTLA

About SPB Spectrum Brands Holdings Inc.

Spectrum Brands Holdings Inc is consumer products and home essentials company. The company is a supplier of consumer batteries, residential locksets, residential builders' hardware, grooming products and personal care products. The company manages the businesses in product-focused segments; Home and Personal Care, which generates maximum revenue; Global Pet Care; and Home and Garden. The company manufactures, markets and distributes its products globally in the North America, Europe, Middle East & Africa, Latin America, and Asia-Pacific. It generates maximum revenue from North America.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: